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Abstract
In the last 5 years a role for β-catenin in the skeleton has been cemented. Beginning with
mutations in the Lrp5 receptor that control β-catenin canonical downstream signals, and
progressing to transgenic models with bone-specific alteration of β-catenin, research has shown
that β-catenin is required for normal bone development. A cell critical to bone in which β-catenin
activity determines function is the marrow-derived mesenchymal stem cell (MSC), where
sustained β-catenin prevents its distribution into adipogenic lineage. β-catenin actions are less well
understood in mature osteoblasts: while β-catenin contributes to control of osteoclastic bone
resorption via alteration of the osteoprotegerin/RANKL ratio, a specific regulatory role during
osteoblast bone synthesis has not yet been determined. The proven ability of mechanical factors to
prevent β-catenin degradation and induce nuclear translocation through Lrp-independent
mechanisms suggests processes by which exercise might modulate bone mass via control of
lineage allocation, in particular, by preventing precursor distribution into the adipocyte pool.
Effects resulting from mechanical activation of β-catenin in mature osteoblasts and osteocytes
likely modulate bone resorption, but whether β-catenin is involved in osteoblast synthetic function
remains to be proven for both mechanical and soluble mediators. As β-catenin appears to support
the downstream effects of multiple osteogenic factors, studies clarifying when and where β-
catenin effects occur will be relevant for translational approaches aimed at preventing bone loss
and terminal adipogenic conversion.
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To activate canonical Wnt signaling, a daunting list of Wnt ligands, their extracellular
binding proteins and receptors, and a host of associated intracellular proteins are recruited,
sorted, ordered, and assembled for the purpose of regulating crucial events in the life of a
cell. Emerging out of this extravaganza of molecules is a single non-redundant and central
molecule, β-catenin [Grigoryan et al., 2008]. Once released from alternative fates—
sequestration, complex binding, or degradation, β-catenin translocates to the nucleus, binds
to Tcf/Lef transcription factors, and triggers cell processes. While β-catenin signals are
evolutionarily ancient [Logan and Nusse, 2004] and have been scientifically scrutinized
since the early 1980s, the importance of β-catenin for bone biology has only recently come
to light. Two clinical observations showed that alterations in Wnt downstream signaling
profoundly impact skeletal morphology. First, a mutation in the Wnt co-receptor Lrp5
leading to a constitutively “on” signal results in high bone mass, as demonstrated in several
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human kindreds [Boyden et al., 2002; Little et al., 2002]. The yin to this yang emerged when
a dominant negative mutation of the same Wnt receptor was found to be associated with low
bone mass [Gong et al., 2001], a finding that delighted bone scientists. While many reports
mounted proving that modifiers of Wnt production and binding were associated with bone
morphology [Williams and Insogna, 2009], the mainstay of Wnt signaling in bone has
largely been through a signaling bottleneck where, emerging on the other side, is the
singular molecule, β-catenin.
One might be tempted to consider that Wnt signaling in bone extends beyond β-catenin.
Investigation of other mutations causing altered bone mass resulted in discovery of
sclerostin [Brunkow et al., 2001], dickkopf-1 [Tian et al., 2003], and sFRP1 [Bodine et al.,
2004], all which interfere with Wnt binding. The LRP5/6 receptor itself has been offered as
a key mechanical regulator of bone mass [Sawakami et al., 2006]. Non-canonical signaling
through Wnt5a, which represses PPARγ transactivation, was suggested to be an equally
important regulator [Takada et al., 2007]. Howsoever, the majority of effects due to these
molecules can be chalked up to their ability to regulate the activation of β-catenin in specific
locations and temporal sequences. In sum, any modification that amplifies or diminishes β-
catenin signaling will result in changes in bone mass.
MODIFICATION OF β-catenin ACTION LEADS TO ALTERATIONS IN BONE
FORMATION AND RESORPTION
Pinpointing the role of β-catenin in bone biology has been served by the ability to alter β-
catenin in a tissue-specific manner. Global knockout of β-catenin in mice leads to
embryonic lethality [Haegel et al., 1995; Grigoryan et al., 2008]. As such, many of the co-
regulators of β-catenin activation have been mutated, leading to the idea that modulation—
up or down—of β-catenin activity would lead to proportionately affected bone similar to
modulation of the activity of the Wnt co-receptor Lrp5/6. An example of this is the
transgenic deletion of Axin2, a molecule which, as part of a multiprotein complex, represses
β-catenin signaling by targeting catenin for proteosomal degradation; after 6 months a
phenotype resulting from increased osteoblast proliferation and differentiation as well as
decreased osteoclast formation (presumably due to β-catenin-induced increases in
osteoprotegerin) was found [Yan et al., 2009]. Nuclear β-catenin protein levels were
increased, and an in vitro deletion of the β-catenin gene in this background reversed the
osteoblast function in culture [Yan et al., 2009].
Loss of function β-catenin mutations were first introduced into osteoprogenitor cells through
mating either Prx1 or Dermo1-Cre to floxed β-catenin transgenics. In 2005 three articles
proved β-catenin’s fundamental role in osteoblast differentiation. After clearly
demonstrating nuclear β-catenin upregulation during skeletal development in the mouse,
Day et al. [2005] conditionally ablated β-catenin in early mesenchymal condensations with a
Dermo1-Cre strategy and showed loss of both osteoblastic and chondrocytic differentiation.
When they utilized a Col2a1-Cre strategy to ablate β-catenin instead, such that β-catenin
knockout occurred later during osteoprogenitor differentiation, expansion of the
hypertrophic chondrocyte region was seen. Similarly, Hill et al. explored β-catenin deletion
in limb and head mesenchyme using Prx1-driven Cre-recombinase and were able to show
arrest of osteoblast differentiation in membranous and endochondral bones. These scientists
also noted that periosteal cells differentiated into chondrocytes in the absence of β-catenin
[Hill et al., 2005]. Importantly their data suggested that while early osteoblast differentiation
may occur in the absence of β-catenin, it ceases at the commitment step where osterix
activation becomes necessary for further osteoblast maturation. The third contemporaneous
article further explicated a role for β-catenin during osteoprogenitor differentiation: a
Dermo1-cre conditional β-catenin knockout studied by Hu et al. [2005] affirmed that β-
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catenin was indispensible to the conversion from an early osteoblast cell expressing low
levels of alkaline phosphatase and collagen to a mature osteoblast with high alkaline
phosphatase and collagen, which goes on to express bone sialoprotein and osteocalcin.
These studies thus confirm that the presence of activated β-catenin is necessary for complete
osteoprogenitor differentiation.
Interestingly, a recent study demonstrated that proper regulation of β-catenin signaling is
critical for mesenchymal lineage allocation in the developing mouse. Knockout of the APC
protein that binds and sequesters β-catenin leads to abnormal skeletal development: use of
the Col2a1 promoter allowed Cre-mediated recombination and deletion of APC in osteoblast
precursors not yet committed to either the osteoblastic or chondrogenic lineage. This leads
to massive β-catenin accumulation in the developing endochondral skeleton and interrupts
normal commitment of mesenchymal precursors into both chondrocytic and osteoblastic
lineages [Miclea et al., 2009]. These authors conclude that β-catenin dosing is critical to
osteoprogenitor entry, specifying that β-catenin availability must be restricted at some point
for proper osteoblasts to develop, and must be nearly absent for Runx2 expressing cells to
enter the chondrocytic lineage. That both dosing and timing of β-catenin availability is
critical for osteoprogenitor development suggests that other micro-environmental factors
interact through focusing β-catenin signaling.
Phenotypic and functional effects of β-catenin after the osteoblast phenotype has been
established are more controversial. Mice lacking β-catenin expression in osteoblasts,
generated using an osteocalcin-directed Cre, had a severe osteopenic phenotype,
complicated by significant increases in osteoclasts [Holmen et al., 2005]. Interestingly, this
osteoblast β-catenin inactivation caused a hyperresorptive mouse phenotype that appeared
more severe than those seen in human dominant negative mutations of LRP5, supporting the
idea that β-catenin shuffles and integrates the transmission of information arriving via Wnt-
independent avenues, as we shall discuss further below. The large accumulation of
osteoclasts in this osteocalcin-directed β-catenin knockout model indicated that effects
extended beyond osteoblasts.
Similarly, Glass et al. [2005] found alterations in osteoclasts after altering β-catenin in
mature osteoblasts. Using gain-of-function (a β-catenin resistant to ubiquitination and
degradation) or loss-of-function β-catenin mutations in osteoblasts, that is, using a collagen
α1(I) promoter either driving the mutant catenin or a Cre-recombinase, this group showed
that while β-catenin overexpression caused lethality due to osteopetrosis, osteoblast numbers
remained at essentially normal levels [Glass et al., 2005]. While the failure of these
investigators to find increased osteoblast numbers during β-catenin overexpression was
certainly due to the later onset of the β-catenin signal as driven by temporal onset of the
collagen α1(I) promoter, osteoclast numbers were decreased as a result of increased
osteoprotegerin secretion. The latter was presumably due to β-catenin induction of
osteoprotegerin in mature osteoblasts. Alternatively, in animals where osteoblasts expressed
the loss-of-function β-catenin mutation, osteoclasts were abundant resulting in a high bone
turnover state with subsequent osteopenia [Glass et al., 2005]. As such, these investigators
reconsidered the role of β-catenin, arriving at their controversial conclusion that β-catenin’s
role as it related to bone was largely to modify gut secretion of serotonin, which then would
secondarily control osteoprogenitor maturation [Yadav et al., 2008]. This opinion not only
blurred the uncontestable role of β-catenin in the early allocation of mesenchymal stem cells
(MSCs) but also appeared to discount their own data showing that the gain-of-function
mutants had increased collagen production. This latter effect on osteoblast function was
replayed in the global Axin2 knockout which expresses not only increased osteoprotegerin
but also collagen 1 by mature osteoblasts [Yan et al., 2009]. Similarly, deletion of the
sclerostin gene led to upregulation of canonical signaling, again with an increase in collagen
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1 and osteocalcin expression [Lin et al., 2009]. At this time, activation of β-catenin in
osteoblasts requires further investigation.
MULTIPLE REGULATORS IMPACT β-catenin ACTIVATION
β-catenin can be found in two primary cellular locations which determine its dual roles in
cell function. A pool of β-catenin associated with the plasma membrane is bound to E-
cadherin and α-catenin in adherens junctions. β-catenin at this location is an essential
component of junction physiology, and accumulates here when incoming signals fail to
activate its nuclear translocation [Cadigan and Peifer, 2009]. The participation of β-catenin
in cell– cell adhesion through these intracellular networks contributes to vertebrate
development through regulation of multiple processes [Stepniak et al., 2009], effects only
beginning to be appreciated in skeletal development. Much more attention has been paid to
the soluble pool of β-catenin found in the cytoplasm, which, upon appropriate stimulation, is
translocated to the nucleus to interact with Tcf/Lef transcription factors. The availability of
β-catenin in the cytoplasm is regulated by a destruction complex consisting of axin, GSK3β,
and APC. Constitutive phosphorylation of β-catenin by cyclin-dependent kinase at serine-45
followed by phosphorylation of the N-terminus by GSK3β targets β-catenin for degradation
by the ubiquitin/proteosome pathway, limiting levels of cytoplasmic β-catenin under resting
conditions. As such, stabilization of β-catenin in the cytosol, enabling nuclear translocation,
depends upon inhibition of β-catenin phosphorylation.
In canonical Wnt signaling, binding of Wnt ligand to its transmembrane receptors frizzled
and LRP5/6 leads to disruption of the β-catenin destruction complex, which appears to be
mediated through dissociation of axin–GSK3β interactions as well as direct inhibition of
GSK3β [MacDonald et al., 2009]. While activation of β-catenin has traditionally been
associated with signaling through the canonical Wnt pathway, it is now recognized that
multiple signaling pathways can activate β-catenin. For example, the putative anti-aging
drug resveratrol has been used in vitro to show that β-catenin increases in the nucleus
through an Lrp5/6- independent fashion, possibly also due to inhibition of GSK3β,
promoting osteoblastic differentiation [Zhou et al., 2009].
As the primary mediator of β-catenin phosphorylation, GSK3β activity is critical for
regulating cytosolic β-catenin levels. Importantly, inhibition of GSK3β with lithium, or
small molecule inhibitors, leads to preservation of β-catenin and magnifies activation—this
results in an increase in osteoprogenitor cells and their activity [Sawakami et al., 2006; Sen
et al., 2009; Yan et al., 2009]. One pathway for inactivation of GSK3β is by phosphorylation
at serine-9, originally described for insulin signaling through Akt/protein kinase B. Studies
in non-skeletal tissues have described β-catenin activation mediated by phosphorylation of
GSK3β by Akt downstream of signaling through heterotrimeric G protein-coupled receptors
[Haq et al., 2003; Castellone et al., 2005], a possibility which will certainly have
implications for the skeleton.
An environmental constraint critical to normal bone modeling and remodeling is generated
through mechanical loading. Mechanical stimulation also impacts processes resulting in β-
catenin activation in bone cells at all stages of maturation, from the undifferentiated MSC
[Sen et al., 2008] to differentiating osteoblasts [Case et al., 2008] to early osteocytes [Xia et
al., 2010]. β-catenin translocates into the nucleus after loading of osteoblasts in response to
either substrate deformation or fluid flow [Norvell et al., 2004; Armstrong et al., 2007],
where it can activate a β-catenin responsive promoter sequence [Hens et al., 2005]. This is
clearly visible in the appearance of activated (dephospho-form) β-catenin in osteoblast like
cells that have been subject to strain, as well as its translocation into the nucleus, as shown
in Figure 1. Accordingly, mechanical loading upregulates β-catenin target genes in vivo
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[Robinson et al., 2006] and in vitro [Lau et al., 2006]. Mechanical regulation of these target
genes might contribute to loading-induced bone formation in several ways. Cyclin D1, a
well-recognized target of β-catenin, induces cell proliferation, and it has been shown that
inhibition of Wnt signals with endostatin are able to prevent fluid shear-induced
proliferation of osteoblasts [Lau et al., 2006]. Mechanical induction of WISP1, a gene
associated with osteogenesis [French et al., 2004], and that we have shown to be rapidly
upregulated by β-catenin activation [Case et al., 2008], may as well support enhanced
osteoblast function.
The mechanical effect on β-catenin target genes is enhanced in the Lrp5 (“on”) transgenic
mouse with high bone mass, where Wnt signaling is constitutively activated [Robinson et
al., 2006]. Conversely, mice with a loss-of-function mutation in LRP5 respond poorly to
local bone loading [Sawakami et al., 2006], which led these authors to suggest that Wnt
binding was necessary for mechanical effects, in particular those due to β-catenin. Our data
suggests that this is not true: in both osteoblasts and MSCs, mechanical activation of β-
catenin was unaffected by the presence of DKK-1, an antagonist that prevents Wnt ligation
of Lrp receptors [Case et al., 2008; Sen et al., 2009]. The ability of mechanical strain to
induce β-catenin activation in the presence of blocked Lrp function has been confirmed
[Sunters et al., 2010]. Perhaps a better interpretation of the Sawakami data is that in
situations where β-catenin availability is modulated, incoming signals which activate or
otherwise impact β-catenin signaling will be proportionately affected. As such, in states
where more β-catenin is actionable, factors—mechanical or chemical—impacting the
proximal side of the bottleneck will cause greater downstream effects.
Tracing the mechanical steps from β-catenin activation proximally to where potential
mechanoreceptors are subject to membrane deformations, revealed that strain-induced
phosphorylation of GSK3β on a site that prevents its binding to β-catenin, thus reducing
catenin ubiquitination and proteolysis [Armstrong et al., 2007; Case et al., 2008]. Even more
rapidly, strain also induced activation of Akt, which likely phosphorylates and inhibits
GSK3β [Case et al., 2008; Sunters et al., 2010, #1711]. Effectors of Akt, or alternate means
by which GSK3β is inhibited by phosphorylation, remain to be identified. PI3K is a possible
candidate as it is known to be activated by mechanical force, and PI3K downstream of
IGF-1 receptor signaling was found to be necessary for late (3 h) strain-induced Akt
activation in osteoblast-like cells [Sunters et al., 2010]. Our own data suggests that PI3K is
not involved in immediate Akt activation and GSK3β inhibition [Case et al., 2008], opening
other possibilities such as integrin-linked kinase (ILK) as intermediaries in mechanical
induction of β-catenin (see Fig. 2).
β-catenin might also be regulated by mechanical or other signals through a change in
membrane sequestration. Membrane proteins, such as cadherins in the adherens junctions,
may be able to regulate the availability of β-catenin, thereby contributing to regulation of
cellular events [Mbalaviele et al., 2006]. An association between β-catenin and N-cadherin
was decreased in osteoblasts in response to fluid flow [Norvell et al., 2004]. Interestingly,
caveolin-1, a structural membrane protein involved in lipid raft compartmentalization, can
also sequester β-catenin, such that overexpression of caveolin-1 damps catenin signaling
[Galbiati et al., 2000], and may contribute to the increased bone mass in the caveolin-1
knockout animal [Rubin et al., 2007].
A CENTRAL ROLE FOR β-catenin IN MSC LINEAGE ALLOCATION
The list of cells involved in determination of skeletal morphology has grown beyond the
osteoblast, osteocyte, and osteoclast. Perhaps the most important with regard to β-catenin
signaling is the bone marrow MSC. The output of this pool of MSCs reflects a reciprocal
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relationship between the numbers of osteoblasts and adipocytes [Akune et al., 2004]. On the
level of the whole animal, a lineage reciprocity between fat and bone is apparent in the case
where the Lrp5 receptor is constitutively activated, where increased trabecular bone is
accompanied by decreased fat in bone marrow [Qiu et al., 2007]. Further, Wnt repression of
adipogenesis in MSCs requires stabilization of β-catenin, which then promotes subsequent
entry into the osteoprogenitor lineage [Kennell and MacDougald, 2005]. Our laboratory has
shown that small molecule inhibitors of GSK3β prevent adipogenesis in MSCs, coincident
with a failure of adipogenic conditions to cause reduction in intracellular active and total β-
catenin levels [Sen et al., 2008]. Importantly, GSK3β inhibition did not prevent
adipogenesis when β-catenin protein was knocked down with siRNAs [Sen et al., 2009] (see
Fig. 3), a fact that underlines the critical role of β-catenin in the proscription of adipocyte
entry. This is further underlined with the fact that the Wnt effect to restrain further
differentiation of preadipocytes by limiting expression of PPARγ can be overcome by
measures that decrease β-catenin signaling [Ross et al., 2000]. As such, it is clear that a
branch point exists where the disposition of MSCs toward the adipocyte lineage critically
hinges on the level of actionable intracellular β-catenin.
Given that mechanical loading activates β-catenin signaling in osteoblasts, we considered
that β-catenin might also be subject to mechanical regulation in MSCs. Our laboratory
recently demonstrated that mechanical signals participate in directly regulating lineage
selection of mesenchymal precursors, mediated in part through mechanical effects on β-
catenin. Specifically, daily mechanical input effectively counteracted an adipogenic
stimulus, disrupting differentiation of C3H10T1/2 mesenchymal progenitor cells [Sen et al.,
2008]. In cultures receiving daily strain, accumulation of intracellular lipid was significantly
reduced, as was expression of PPARγ and adiponectin. Mechanical signals completely
prevented the progressive decrease in β-catenin that was found to accompany adipogenic
transformation in MSCs. Importantly, small interfering RNA targeting β-catenin blocked the
ability of strain to inhibit adipogenesis of both C3H10T1/2 and marrow-derived MSCs [Sen
et al., 2009]. Mechanical preservation of β-catenin in MSCs was shown to be downstream of
mechanical inactivation of GSK3β and this effect was independent of signaling through Wnt
receptors, consistent with the signaling pathway described in osteoblasts. Beyond the branch
point between adipogenesis and osteogenesis, β-catenin signaling appears to be secondary to
a host of osteogenic signals including BMPs, hedgehog, and activation of SMAD signaling
pathways. Actions of β-catenin may be influenced by BMP signaling, as there is crosstalk
between the two pathways [Itasaki and Hoppler, 2010]. Furthermore, we were able to show
that MSCs subject to a mechanical regimen while under adipogenic constraints were able to
respond rapidly and completely to BMP2 due to the high levels of β-catenin induced by the
daily strain [Sen et al., 2008].
Recently, Wnt1 dosing experiments in human MSCs allowed investigators to argue that
Wnts, presumably via β-catenin, has variable effects on different pools of MSCs, such that
early canonical signaling prevents adipogenesis and promotes expansion of the
osteoprogenitor clone, which then must experience decreased TCF4 signaling, or at the least,
other signals, to achieve the mature osteoblastic phenotype [Liu et al., 2009]. Whether β-
catenin exercises a dominant influence beyond the branch point between adipogenesis and
osteogenesis is not firmly established. As discussed earlier, commitment within the
osteoblast lineage does appear to require β-catenin activity: the dermo1-Cre conditional β-
catenin knockout showed that E18.5 embryos had a cartilaginous skeleton but no bone or
functioning osteoblasts [Hu et al., 2005]. Similarly, an Osterix-cre mouse where conditional
ablation of the β-catenin gene was restricted to late osteoprogenitors, the normal size
cartilaginous skeleton was not mineralized [Rodda and McMahon, 2006]. Importantly, the
obverse, that is stabilization of β-catenin signaling in osterix expressing osteoprogenitors,
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resulted in premature mineralization and increased proliferation of preosteoblasts [Rodda
and McMahon, 2006], supporting a role for β-catenin in controlling late osteoblast function.
In sum, although the activation of β-catenin in differentiating osteoprogenitors represents an
incompletely understood integration of multiple signals from the micro-environment, the
contribution of β-catenin towards delineation of lineage within the MSC pool is
incontrovertible. β-catenin prevents adipogenic differentiation, supports early osteochondro-
progenitor entry, and its absence after this point promotes entry into the chondrocytic
pathway.
β-catenin: MAJOR OR SUPPORTING PLAYER IN MECHANICAL SIGNAL
TRANSDUCTION?
Mechanical information is critical to functional bone morphology. Adaptation to mechanical
loading is a tissue-level response that involves temporal and spatial coordination of bone
cells, and thus in vivo models of bone adaptation provide primary insights into the cellular
events leading to new bone formation. Experimental data suggests that mechanical signals
can activate the resident quiescent osteoblast population: a role for β-catenin seems logical
here, and indeed Lrp5 resistant animals have a poor mechanical response to loading
[Sawakami et al., 2006]. In the case of the osteocyte, which serves as a mechanical sensor
controlling bone resorption in response to unloading [Tatsumi et al., 2007], it is likely that
β-catenin will be shown to be an important signal node in osteocyte induction of
osteoclastogenesis. Bone formation upon re-loading, however, proceeds in the absence of
functional osteocytes [Tatsumi et al., 2007], and no other data yet exists to show that
osteocytes rely on mechanically induced β-catenin signaling.
The contribution of β-catenin towards delineation of lineage within the MSC pool is,
however, well established. As such, in considering the role of β-catenin as an effector of
mechanical signaling in bone, we can achieve some certitude by focusing our comments on
mechanical influences on MSC recruitment and differentiation. Animal studies suggest that
MSC lineage allocation within the marrow cavity is subject to mechanical input, with
exercise increasing the proportion of marrow precursors assigned to the osteogenic lineage
[David et al., 2007; Menuki et al., 2008]. As adipocyte numbers in the marrow are
coordinately reduced by exercise in these studies, this pro-osteogenic effect may be due in
part to a blocking of MSCs entering the adipogenic pathway, thus preserving a pool of cells
available for alternate lineages. Furthermore, MSC allocation has been shown to be affected
in vivo by exogenous vibration, a novel strategy for delivering therapeutic loading signals
[Luu et al., 2009]. Indeed, in vitro experimentation has demonstrated that mechanical signals
directly inhibit adipocyte differentiation of MSCs [Sen et al., 2008] and that mechanical
activation of β-catenin is critical to this effect [Sen et al., 2009].
Our lab also demonstrated that mechanical strain induced COX2 expression [Sen et al.,
2009]. The mechanical response of COX2, interestingly, was unchanged in the presence of
β-catenin knockdown by small interfering RNA, in contrast to mechanical inhibition of
adipogenesis. Similarly to its role in preserving β-catenin, mechanical inactivation of
GSK3β was necessary for strain effects on COX2. In this case, mechanical inactivation of
GSK3β was found to have a secondary effect to promote nuclear accumulation of NFATc1
through preventing GSK3β’s re-phosphorylation of nuclear NFATc1 with reentry to the
cytoplasm [Sen et al., 2009]. Silencing of NFATc1 with siRNA prevented mechanical
stimulation of COX2. Importantly, strain effects on NFATc1 and COX2 did not require β-
catenin (see Fig. 3). Since an increase in COX2 is associated with differentiation of
osteoblasts [Zhang et al., 2002], mechanical upregulation of COX2 is likely to be only one
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of a host of mechanically susceptible pathways which influence bone formation. As such,
the primacy of β-catenin is not established.
Limited in vitro data exist to suggest a direct role for mechanical loading in promoting
osteogenic differentiation of MSCs in the absence of added factors. Mechanical signals that
activate β-catenin, as well as other effector molecules, may provide too weak of a
differentiation stimulus by themselves, but may enhance entry into the osteogenic lineage
when working in concert with other signals such as BMP-2 [Case et al., 2008; Sen et al.,
2008]. Taking this idea a step further, mechanical protection of β-catenin levels appears to
assume a permissive role, allowing proliferation and expansion of early—but not committed
—osteoprogenitors, and enabling these cells to resist differentiation factors that promote
other lineages, for example, adipogenic or chondrogenic stimuli. As such, when soluble
factors promoting late osteoblast development exceed some threshold, the β-catenin brake
on differentiation would be released in favor of osteogenesis (see Fig. 4).
Activation of β-catenin is certainly a strong signal contributing to osteoclastogenesis via
regulation of RANKL expression in osteoblasts, a fact consistent with the mechanical
downregulation of RANKL [Rubin et al., 2000]. Restriction of RANKL is likely prima facie
to the ability of exercise to inhibit bone resorption. In transgenic animals where a form of β-
catenin expressed in osteoblasts was stabilized by preventing targeting by GSK3β,
osteopetrosis developed [Glass et al., 2005]. Whether the mechanical inhibition of RANKL
absolutely requires β-catenin is not yet known.
It is understood that activation of β-catenin is not responsible for transducing all of the
various cellular events associated with mechanical stimulation in bone cells; rather multiple
parallel signaling pathways with various downstream effector molecules are initiated by
membrane deformations to mediate these cellular effects, as reviewed in [Rubin et al.,
2006]. Integrin-associated proteins, including focal adhesion kinase (FAK) and ILK, are
likely candidates for initiating mechanical signaling cascades in bone cells. Signaling
through G proteins and G protein-coupled receptors may contribute to mechanical activation
of ERK 1/2 MAP kinase and PI3 kinase, respectively. It is noteworthy that several of these
pathways are known to regulate activity of GSK3β in response to chemical factors,
suggesting a possible point of convergence in response to mechanical inputs. GSK3β has
other effectors besides β-catenin, as we have shown in the case of NFATc1 above [Sen et
al., 2009]. At this point, it is clear that activation of β-catenin is a major target of mechanical
input, at the very least an important node where biophysical factors control MSC cell fate,
but its role in other, less well-defined responses to loading, such as the mechanosensory
response of osteocytes, remains to be elucidated.
CONCLUSION
In summary, β-catenin has an irreplaceable role in bone marrow MSCs, where temporal and
dosing effects regulate lineage allocation (reviewed in Fig. 4). There are at least two critical
decision points where β-catenin activity exerts predominant control—at the selection node
between adipocyte and osteoprogenitor progression, and later, when a portion of
osteoprogenitor cells enter the chondrogenic lineage. At each of these points, the availability
or unavailability of β-catenin determines lineage. In the case of MSCs exposed to a micro-
environment which favors development of a fat phenotype, elevated levels of β-catenin
protected from proteosomal degradation prevent adipogenesis. At this stage, an elevated β-
catenin level appears to be permissive signal for progression into the osteoblast phenotype
rather than a primary stimulus; it is likely that other factors, in particular those in the BMP
and hedgehog signaling pathways, direct the osteoblastic transformation. In terms of
chondrogenesis, less is known, but it also appears that β-catenin again prevents allocation
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into chondrocyte lineage; as such β-catenin levels must fall, similarly to the loss required for
adipogenesis, before chondrogenesis can occur. As such, during MSC development β-
catenin plays a permissive role, preventing final lineage assignment.
An effect of β-catenin in differentiated bone cells, including osteoblasts and osteocytes,
remains inferential—while β-catenin is available for activation, and has been shown to be
regulated by a multitude of factors both physical and chemical, downstream targets other
than osteoprotegerin with affects on osteoclast recruitment, are not well understood. This
invites further thought and study.
Mechanical stimulation, known to promote bone formation, and certainly to prevent bone
resorption, has been proven to regulate β-catenin levels in MSCs and in differentiated
osteoblasts and osteocytes both in vitro and in vivo. Mechanical signals prevent β-catenin
degradation through regulation of GSK3β activity by Wnt independent means. Wnt
signaling, as well as effects on β-catenin via other growth receptors, in response to
mechanical input may contribute as well. The capacity of mechanical signals to promote an
osteogenic environment through preventing alternate lineage selection suggests many
opportunities whereby biophysical factors could be used to regulate the output of the
marrow MSC pool.
In closing, the conjunction of β-catenin as a key regulator of MSC lineage allocation, and
the ability of biophysical factors to regulate both β-catenin and MSC cell fate, calls for
research that will define the optimal way to dose both of these factors—exercise and β-
catenin— to promote the health and strength of the skeleton.
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Mechanical strain activates β-catenin translocation. Osteoblast cells were subjected to strain
for 15–60 min and immunostained for active β-catenin (top) and nuclei stained with DAPI
(middle). Images of active β-catenin and DAPI staining were merged (bottom) to show
active β-catenin had translocated to the nucleus. Increased nuclear active β-catenin was
detected 15 min after beginning mechanical strain by confocal microscopy. Adapted from
Case et al. [2008].
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β-catenin activation by mechanical factors is both direct and indirect. β-catenin signaling is
repressed both by sequestration with cadherins and a-catenin at the membrane and by
interactions with a multiprotein destruction complex, which targets cytosolic catenin for
proteosomal degradation upon phosphorylation by GSK3β. Mechanical signals (strain/
deformation, fluid shear, cell acceleration/vibration) in bone cells inhibit GSK3β activity,
with Akt being a likely effector by phosphorylation of GSK3β at serine-9. Rapid Akt
phosphorylation after mechanical input may occur directly via ILK with involvement of
FAK, or more gradually through receptor-dependent actions on PI3K. Prolonged mechanical
signaling may also enhance binding of Wnt to its co-receptors, leading to disruption of the
destruction complex. Once released from alternative fates such as sequestration, complex
binding, or degradation, β-catenin will translocate to the nucleus, binding to Tcf/Lef
transcription factors and triggering cell processes.
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β-catenin is activated by strain and is necessary to transmit both mechanical and
pharmacological signals that result in inhibition of adipogenesis. A: MSCs in adipogenic
medium were analyzed after exposure to daily strain regimen for 4 days, showing that both
active and total β-catenin are increased by strain. During this time adiponectin, representing
adipocyte conversion, is limited by mechanical strain. Note also that COX2 was induced by
strain. B: MSCs were treated with siRNA scrambled (siScr) or targeting β-catenin (siCat)
prior to beginning the strain regimen. Strain was unable to prevent adipogenesis when β-
catenin was knocked down (densitometry shown below). β-catenin was not necessary for
strain induction of COX2. C: Similarly, when adipogenesis was prevented by inhibiting
GSK3β with the small molecule SB415286 (20 mm), siRNA targeting β-catenin interfered
with this effect. The pharmacologic effect to induce COX2, again, did not require β-catenin
to be effective. Adapted from Sen et al. [2009].
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β-catenin restricts MSC distribution to non-osteoprogenitor lineages. Effects of β-catenin
availability and activation prevent loss of precursor cells to the adipogenic phenotype. Once
the MSC has become an osteochondroprogenitor, decreases in β-catenin allow diversion to
the chondrocytic lineage. While elevated β-catenin appears to support the mature osteogenic
phenotype, it has yet not been shown to be a singular impetus for this differentiation
pathway.
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